Evidence map›Paper›PMID 34507972›Full record

ReviewCancer prevention research (Philadelphia, Pa.)2021

High-burden Cancers in Middle-income Countries: A Review of Prevention and Early Detection Strategies Targeting At-risk Populations.

Anna J Dare, Gregory C Knapp, Anya Romanoff, Olalekan Olasehinde, Olusola C Famurewa, Akinwumi O Komolafe, Samuel Olatoke, Aba Katung, Olusegun I Alatise, T Peter Kingham

Open access · bronzeAbstract readReview
In one paragraph

Review in Cancer prevention research (Philadelphia, Pa.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Establishment of Integrated Hospital-Based Supportive and Palliative Services: An Experience from Iran.International journal of hematology-oncology and stem cell research · 2026
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Identification of apoptosisZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Article
  19. Review
  20. A Global Survey of Self-Reported Cancer Screening Practices by Health Professionals for Kidney Transplant Candidates and Recipients.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Anna J DareDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Gregory C KnappGlobal Cancer Disparities Initiative, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0002-9305-1709
Anya RomanoffGlobal Cancer Disparities Initiative, Memorial Sloan Kettering Cancer Center, New York, New York.
Olalekan OlasehindeDepartment of Surgery, Obafemi Awolowo University, Ile-Ife, Nigeria.
Olusola C FamurewaDepartment of Surgery, Obafemi Awolowo University, Ile-Ife, Nigeria.
Akinwumi O KomolafeDepartment of Morbid Anatomy and Forensic Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.ORCID 0000-0002-1392-2296
Samuel OlatokeDepartment of Surgery, University of Ilorin, Ilorin, Nigeria.
Aba KatungDepartment of Surgery, Federal Medical College - Owo, Owo, Nigeria.
Olusegun I AlatiseDepartment of Surgery, Obafemi Awolowo University, Ile-Ife, Nigeria.
T Peter KinghamDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. kinghamt@mskcc.org.
Obafemi Awolowo University · NGMemorial Sloan Kettering Cancer Center · USDalhousie University · CAFederal Medical Centre · NGMount Sinai Health System · USUniversity of Ilorin · NG

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Cancer incidence is rising in low- and especially middle-income countries (MIC), driven primarily by four high-burden cancers (breast, cervix, lung, colorectal). By 2030, more than two-thirds of all cancer deaths will occur in MICs. Prevention and early detection are required alongside efforts to improve access to cancer treatment. Successful strategies for decreasing cancer mortality in high-income countries are not always effective, feasible or affordable in other countries. In this review, we evaluate strategies for prevention and early detection of breast, cervix, lung, and colorectal cancers, focusing on modifiable risk factors and high-risk subpopulations. Tobacco taxation, human papilloma virus vaccination, cervical cancer screen-and-treat strategies, and efforts to reduce patient and health system-related delays in the early detection of breast and colorectal cancer represent the highest yield strategies for advancing cancer control in many MICs. An initial focus on high-risk populations is appropriate, with increasing population coverage as resources allow. These strategies can deliver significant cancer mortality gains, and serve as a foundation from which countries can develop comprehensive cancer control programs. Investment in national cancer surveillance infrastructure is needed; the absence of national cancer data to identify at-risk groups remains a barrier to the development of context-specific cancer control strategies.

Indexed as

Developing CountriesUterine Cervical NeoplasmsEarly Detection of CancerFemaleHumansIncomeRisk Factors

Identifiers

PMID34507972
PMCPMC8639660
OpenAlexW3198821070

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.